Related Experiment Videos
Biologic responses to IFN-alpha administration in humans
E P Corssmit1, J de Metz, H P Sauerwein
1Department of Endocrinology, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands. e.p.corssmit@amc.uva.nl
Summary
Interferon-alpha (IFN-alpha), discovered decades ago, is a therapeutic agent for viral diseases and cancer. Its complex mechanisms interact with immune, neuroendocrine, and metabolic systems, making clinical effects challenging to pinpoint.
Area of Science:
- Immunology
- Endocrinology
- Oncology
Background:
- Interferon-alpha (IFN-alpha) was discovered over 40 years ago.
- Therapeutic registration for IFN-alpha took many years.
- IFN-alpha possesses unique antiviral and antitumor properties.
Purpose of the Study:
- To review the therapeutic applications of IFN-alpha.
- To explore the complex physiological interactions of IFN-alpha.
- To discuss the challenges in linking IFN-alpha's biological actions to clinical outcomes.
Main Methods:
- Literature review of IFN-alpha's discovery and therapeutic use.
- Analysis of IFN-alpha's interactions with physiological systems.
- Discussion of the complexity of IFN-alpha's mechanisms of action.
Main Results:
- IFN-alpha is registered for both antiviral and antitumor indications.
- IFN-alpha interferes with immune, neuroendocrine, and metabolic systems.
- The precise mechanisms linking IFN-alpha's biological actions to clinical effects are complex and difficult to establish.
Conclusions:
- IFN-alpha is a versatile therapeutic agent with broad physiological effects.
- Understanding the intricate mechanisms of IFN-alpha is crucial for optimizing its clinical use.
- Further research is needed to fully elucidate the complex relationship between IFN-alpha's actions and patient outcomes.